Gynecare Thermachoice
In stock
Reconfirm the price with seller
- Customer pickup,
- Courier
- In detail
Products of other enterprises
Description
Long term clinical data show
Proven efficiency and patient satisfaction
- 95.1 success rate (return to normal bleeding or less) among patients treated at 5 years
- 73.7% of patients treated report decreased dymenorrhea at 3 years
- 64% of patients report none to mild premenstrual symptoms at 3 years
- 93% of patients ablation system with experience in over 325,000 patients worldwide
Designed for Safety
- No incision made
- Perforation detection system that operates prior to and during the procedure.
- Silicone balloon
- Latex free
- Softly conforms to the contours of a woman's uterus
- Rate of reported complications is only 0.31 per 1000 cases- lowest of all FDA- approved endometrial ablation technologies as of May, 2003
- Hormone free
- Definite
- Hormone free
- Minimally Invasive
Contact the seller
Gynecare Thermachoice